Connect with us

Healthcare

Trump says ‘I am very proud of’ the COVID-19 vaccine

Published

on

Screen Shot 2021 08 18 at 10.35.13 AM

[brid autoplay=”true” video=”698512″ player=”23886″ title=”moderna%20looking%20good%206%20million%20doses” duration=”24″ description=”undefined” uploaddate=”2021-01-04″ thumbnailurl=”//cdn.brid.tv/live/partners/18168/thumb/698512_t_1609803251.png” contentUrl=”//cdn.brid.tv/live/partners/18168/sd/698512.mp4″]


By Jenny Goldsberry

Former President Trump blasted the Food and Drug Administration, claiming he had to “push” them during his term. Trump appeared on Hannity Tuesday to talk about, as he put it, his “great achievement” that was the COVID-19 vaccine.

“As far as a vaccine, I am very proud of it,” Trump said. “I pushed the FDA like they have never been pushed.” First, Dr. Anthony Fauci told Trump it would initially take three to five years to release a vaccine. Instead, it took nine months. Now, over 70% of Americans have received at lease one shot.

“I consider it a great achievement,” Trump said. “I would love people to take the vaccine. In the meantime, wear your mask if you want.” Meanwhile, the FDA also continues to encourage Americans to get the vaccine.

Trump himself got the vaccine during his term as president. At the time, the White House didn’t announce which vaccine he had. He, along with then First Lady Melania received their shots after contracting the virus.

You can follow Jenny Goldsberry on Twitter @jennyjournalism.

You may like

Continue Reading

Healthcare

TN Republican introduces legislation to fight opioid shipments into U.S.

Published

on

Fentanyl 1031234188 scaled

Tennessee Republican Representative Diana Harshbarger is attempting to fight the opioid crisis and epidemic through new legislation. Introduced Friday, Harshbarger told the Daily Caller:

The Daily Caller first obtained a copy of the legislation, which addresses what Harshbarger calls a “loophole.” The legislation amends the Controlled Substances Act to specifically require registrants to investigate reports of suspicious orders of controlled substances and halt them if necessary. Under the version of the act currently in force, drug manufacturers and distributors are only required to report suspicious orders of opioids and other controlled substances to the DEA.

“Breaking the opioid epidemic’s stranglehold on our nation is one of my foremost priorities. In an effort to do so, my colleagues and I have identified a loophole that allows distributors to continue order fulfillment, even under suspicious circumstances.”

“My bill closes that loophole with the requirements and guardrails needed to ensure these addictive and potentially dangerous drugs do not fall into the wrong hands while the DEA investigates. The future of our nation depends on us solving the addiction crisis, and this is a step towards that outcome” Harshbarger continued.

The Daily Caller reports:

According to a congressional report released in September, the opioid crisis cost the U.S. $1.5 trillion during the COVID-19 pandemic.

The CDC says 93,331 people died from overdoses in the U.S. in 2020, the highest in 50 years. Opioid-related deaths made up nearly three-quarters of the total.

Pharmaceutical companies have been blamed for contributing to the opioid epidemic. The Department of Justice is currently suing the pharmaceutical company AmerisourceBergen over allegations the company failed to report suspicious orders of opioids to federal law enforcement.

You may like

Continue Reading
Advertisement
-->

Trending Now

Advertisement
-->

Trending

Proudly Made In America | © 2022 M3 Media Management, LLC